press release
Steve Collens, CEO, MATTER HealthTech Incubator
Collens called it “an incredibly dynamic and exciting time for innovation and entrepreneurship in healthcare.”
“The ability to collect and store and analyze and act on data has evolved dramatically in the past few years,” he said. “It’s been an evolution involving everything from cloud storage to analytics to the penetration of electronic medi…
Read more
press release
MATTER, Chicago’s new entrepreneurship and innovation hub for next-generation health IT, medical device, diagnostics and biopharma companies, today launched its Mentors-in-Residence program. MATTER’s mentors-in-residence are veteran entrepreneurs, executives and investors who will help advise the incubator’s member companies.
MATTER’s first members-in-residence are: Jordan Dolin, founder of Em…
Read more
press release
Public and Private Investment now Exceeds $8M with MATTER on Track to Launch in Early 2015
MATTER has secured private-sector commitments of $4.4 million to support Chicago’s new entrepreneurship and innovation hub for next-generation health IT, medical device, diagnostics and biopharma companies. The $4.4 million in private investment complements the $2.5 million grant and $1.5 million loan pr…
Read more
press release
Matter, the health care-technology incubator being created at the Merchandise Mart, has lined up $4.4 million in private funding, attracting support from some of the industry’s biggest players.
The private-sector commitments exceed the $4 million in state funding that launched the incubator,which is expected to open early next year.
The idea of a health-technology incubator, along the lines o…
Read more
press release
MATTER has secured another $4.4 million in funding, this time from some big names in the private sector.
Chicago’s healthcare tech hub MATTER, which is set to open in early 2015, now has an initial capital commitment of more than $8 million. The latest round, which includes all private sector investments, involved industry leaders like AbbVie, Marathon Pharmaceuticals and Astellas Pharma.
MAT…
Read more